Cargando…
Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma
Glioblastoma (GBM) is the most aggressive primary brain tumor, with a median survival at diagnosis of 16–20 months. Metabolism represents a new attractive therapeutic target; however, due to high intratumoral heterogeneity, the application of metabolic drugs in GBM is challenging. We characterized t...
Autores principales: | Duraj, Tomás, García-Romero, Noemí, Carrión-Navarro, Josefa, Madurga, Rodrigo, Ortiz de Mendivil, Ana, Prat-Acin, Ricardo, Garcia-Cañamaque, Lina, Ayuso-Sacido, Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922554/ https://www.ncbi.nlm.nih.gov/pubmed/33498369 http://dx.doi.org/10.3390/cells10020202 |
Ejemplares similares
-
Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
por: Duraj, Tomás, et al.
Publicado: (2021) -
Suppressor of fused associates with dissemination patterns in patients with glioma
por: Peris-Celda, María, et al.
Publicado: (2022) -
Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma
por: García-Romero, N., et al.
Publicado: (2020) -
DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients
por: García-Romero, Noemí, et al.
Publicado: (2016) -
BRAF V600E Detection in Liquid Biopsies from Pediatric Central Nervous System Tumors
por: García-Romero, Noemi, et al.
Publicado: (2019)